ID
19646
Description
S8814A Biomarkers in Predicting Outcome in Postmenopausal Women With Hormone Receptor-Positive, Node-Positive Breast Cancer Treated With Tamoxifen With or Without Cyclophosphamide, Doxorubicin, and Fluorouracil; ODM derived from: https://clinicaltrials.gov/show/NCT00897091
Lien
https://clinicaltrials.gov/show/NCT00897091
Mots-clés
Versions (1)
- 18/01/2017 18/01/2017 -
Téléchargé le
18 janvier 2017
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Breast Cancer NCT00897091
Eligibility Breast Cancer NCT00897091
- StudyEvent: Eligibility
Similar models
Eligibility Breast Cancer NCT00897091
- StudyEvent: Eligibility
C0746319 (UMLS CUI [1,2])
C3258246 (UMLS CUI [1,3])
C0087111 (UMLS CUI [2,1])
C0008976 (UMLS CUI [2,2])
C0087095 (UMLS CUI [3,1])
C0008976 (UMLS CUI [3,2])
C1519524 (UMLS CUI [1,2])
C4071762 (UMLS CUI [1,3])
C0470187 (UMLS CUI [1,4])
C1883469 (UMLS CUI [2,1])
C4071762 (UMLS CUI [2,2])
C0470187 (UMLS CUI [2,3])
C0205410 (UMLS CUI [1,2])
C1519524 (UMLS CUI [1,3])
C0475358 (UMLS CUI [2,1])
C0205410 (UMLS CUI [2,2])
C1883469 (UMLS CUI [2,3])
C0205171 (UMLS CUI [1,2])
C0470187 (UMLS CUI [1,3])
C0599161 (UMLS CUI [2,1])
C1979963 (UMLS CUI [2,2])
C1879533 (UMLS CUI [2,3])
C0205410 (UMLS CUI [1,2])
C0599161 (UMLS CUI [1,3])
C0002778 (UMLS CUI [1,4])
C1709318 (UMLS CUI [2])
C0449864 (UMLS CUI [1,2])
C1510992 (UMLS CUI [1,3])
C1882115 (UMLS CUI [1,4])
C0017337 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C1706462 (UMLS CUI [2,3])
C1511726 (UMLS CUI [1,2])
C0449438 (UMLS CUI [1,2])
C1562928 (UMLS CUI [2])